Literature DB >> 8584364

Field effectiveness of erythromycin prophylaxis to prevent pertussis within families.

G De Serres1, N Boulianne, B Duval.   

Abstract

To evaluate the field effectiveness of erythromycin prophylaxis for pertussis within families, a retrospective cohort study was conducted among 246 families. Overall 41% of the subjects (387 of 940) had been sick. The secondary attack rate was 65% for infants younger than 2 years, 54% for those 2 to 4 years old and 39% for children 5 to 9 years old, and it declined thereafter. The secondary attack rate decreased from 25% in families without prophylaxis to 17% in families with prophylaxis. The protection induced by prophylaxis did not vary with age or vaccination status. When prophylaxis was used before the onset of a secondary case, the secondary attack rate was 4% compared with 35% when given after a secondary case (P < 0.001). Erythromycin prophylaxis seems to be efficient in preventing secondary cases but is most useful when administered before the occurrence of the first secondary case.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8584364     DOI: 10.1097/00006454-199511000-00009

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  10 in total

1.  Antibacterial agents and release of periplasmic pertussis toxin from Bordetella pertussis.

Authors:  K A Craig-Mylius; A A Weiss
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

2.  Pertussis is increasing in unimmunized infants: is a change in policy needed?

Authors:  S Ranganathan; R Tasker; R Booy; P Habibi; S Nadel; J Britto
Journal:  Arch Dis Child       Date:  1999-03       Impact factor: 3.791

3.  Is pertussis being considered as a cause of persistent cough among adults?

Authors:  Carine Couzigou; Antoine Flahault
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

4.  The role of the acellular pertussis vaccine and the demise of 'Pertussis Pete'.

Authors:  J M Conly; B L Johnston
Journal:  Can J Infect Dis       Date:  2001-01

Review 5.  State of art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis.

Authors:  J E Hoppe
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

Review 6.  Which strategy for pertussis vaccination today?

Authors:  Dorota Z Girard
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

7.  A comparison of 2 strategies to prevent infection following pertussis exposure in vaccinated healthcare personnel.

Authors:  William P Goins; Kathryn M Edwards; Cindy L Vnencak-Jones; Michael T Rock; Melanie Swift; Valerie Thayer; William Schaffner; Thomas R Talbot
Journal:  Clin Infect Dis       Date:  2012-01-11       Impact factor: 9.079

8.  A simplified method for testing Bordetella pertussis for resistance to erythromycin and other antimicrobial agents.

Authors:  B C Hill; C N Baker; F C Tenover
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

9.  Pertussis post-exposure prophylaxis among household contacts: a cost-utility analysis.

Authors:  Nisha Thampi; Ipek Gurol-Urganci; Natasha S Crowcroft; Beate Sander
Journal:  PLoS One       Date:  2015-03-06       Impact factor: 3.240

Review 10.  Occupational Health Update: Focus on Preventing the Acquisition of Infections with Pre-exposure Prophylaxis and Postexposure Prophylaxis.

Authors:  David J Weber; William A Rutala
Journal:  Infect Dis Clin North Am       Date:  2016-09       Impact factor: 5.982

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.